"The
Report Prader-Willi Syndrome (PWS) - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global Markets Directs,
Prader-Willi
Syndrome (PWS)
- Pipeline Review, H2 2016, provides an overview of the Prader-Willi
Syndrome (PWS) pipeline landscape.
The report provides
comprehensive information on the therapeutics under development for
Prader-Willi Syndrome (PWS), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Prader-Willi Syndrome (PWS) and
features dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/794410
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Prader-Willi Syndrome (PWS)
-
The report reviews pipeline therapeutics for Prader-Willi Syndrome
(PWS) by
companies
and universities/research institutes based on information derived
from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Prader-Willi Syndrome (PWS)
therapeutics and enlists all their major and minor projects
-
The report assesses Prader-Willi Syndrome (PWS) therapeutics based on
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Prader-Willi Syndrome (PWS)
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Prader-Willi Syndrome (PWS)
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Prader-Willi Syndrome (PWS) pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
Of Content
Table
of Contents 2
List
of Tables 5
List
of Figures 5
Introduction
6
Global
Markets Direct Report Coverage 6
Prader-Willi
Syndrome (PWS) Overview 7
Therapeutics
Development 8
Pipeline
Products for Prader-Willi Syndrome (PWS) - Overview 8
Pipeline
Products for Prader-Willi Syndrome (PWS) - Comparative Analysis 9
Prader-Willi
Syndrome (PWS) - Therapeutics under Development by Companies 10
Prader-Willi
Syndrome (PWS) - Therapeutics under Investigation by
Universities/Institutes 11
Prader-Willi
Syndrome (PWS) - Pipeline Products Glance 12
Late
Stage Products 12
Clinical
Stage Products 13
Early
Stage Products 14
Prader-Willi
Syndrome (PWS) - Products under Development by Companies 15
Prader-Willi
Syndrome (PWS) - Products under Investigation by
Universities/Institutes 16
Prader-Willi
Syndrome (PWS) - Companies Involved in Therapeutics Development 17
Alize
Pharma SAS 17
Essentialis,
Inc. 18
Ferring
International Center S.A. 19
Helsinn
Healthcare S.A. 20
LG
Life Science LTD. 21
Prader-Willi
Syndrome (PWS) - Therapeutics Assessment 22
Assessment
by Monotherapy Products 22
Assessment
by Target 23
Assessment
by Mechanism of Action 25
Assessment
by Route of Administration 27
Assessment
by Molecule Type 29
Drug
Profiles 31
AZP-531
- Drug Profile 31
Product
Description 31
Mechanism
Of Action 31
R&D
Progress 31
carbetocin
- Drug Profile 34
Product
Description 34
Mechanism
Of Action 34
R&D
Progress 34
diazoxide
- Drug Profile 35
Product
Description 35
Mechanism
Of Action 35
R&D
Progress 35
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment